Publikationen von Heike Endepols

Endepols, H.; Anglada-Huguet, M.; Mandelkow, E.; Schmidt, Y.; Krapf, P.; Zlatopolskiy, B. D.; Neumaier, B.; Drzezga, A.: Assessment of the in vivo relationship between cerebral hypometabolism, Tau deposition, TSPO expression, and synaptic density in a tauopathy mouse model: a multi-tracer PET study. Molecular Neurobiology (angenommen)

Endepols, H.; Zlatopolskiy, B. D.; Zischler, J.; Alavinejad, N.; Apetz, N.; Vus, S.; Drzezga, A.; Neumaier, B.: Imaging of cerebral tryptophan metabolism using 7-[18F]FTrp-PET in a unilateral Parkinsonian rat model. NeuroImage 247, 118842 (2022)

Walter, N.; Bertram, J.; Drewes, B.; Bahutsky, V.; Timmer, M.; Schütz, M. B.; Krämer, F.; Neumaier, F.; Endepols, H.; Neumaier, B. et al.; Zlatopolskiy, B. D.: Convenient PET-tracer production via SuFEx 18F-fluorination of nanomolar precursor amounts. European Journal of Medicinal Chemistry 237, 114383 (2022)

Apetz, N.; Paralikar, K.; Neumaier, B.; Drzezga, A.; Wiedermann, D.; Iyer, R.; Munns, G.; Scott, E.; Timmermann, L.; Endepols, H.: Towards chronic deep brain stimulation in freely moving hemiparkinsonian rats: applicability and functionality of a fully implantable stimulation system. Journal of Neural Engineering 18 (3), 036018 (2021)

Hoffmann, C.; Evcüman, S.; Neumaier, F.; Zlatopolskiy, B. D.; Humpert, S.; Bier, D.; Holschbach, M.; Schulze, A.; Endepols, H.; Neumaier, B.: [F-18]ALX5406: A brain-penetrating prodrug for GlyT1-specific PET imaging. ACS Chemical Neuroscience 12 (18), S. 3335 - 3346 (2021)

Krämer, F.; Groner, B.; Hoffmann, C.; Craig, A.; Brugger, M.; Drzezga, A.; Timmer, M.; Neumaier, F.; Zlatopolskiy, B. D.; Endepols, H. et al.; Neumaier, B.: Evaluation of 3-l- and 3-d-[18F]Fluorophenylalanines as PET Tracers for Tumor Imaging. Cancers / Molecular Diversity Preservation International (MDPI) 13 (23), 6030 (2021)

Meinhardt, M. W.; Pfarr, S.; Fouquet, G.; Rohleder, C.; Meinhardt, M. L.; Barroso-Flores, J.; Hoffmann, R.; Jeanblanc, J.; Paul, E.; Wagner, K. et al.; Hansson, A. C.; Köhr, G.; Meier, N.; Halbach, O. v. B. u.; Bell, R. L.; Endepols, H.; Neumaier, B.; Schönig, K.; Bartsch, D.; Naassila, M.; Spanagel, R.; Sommer, W. H.: Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. Science Advances 7 (47), eabh2399 (2021)

Schöbi, D.; Homberg, F.; Frässle, S.; Endepols, H.; Moran, R. J.; Friston, K. J.; Tittgemeyer, M.; Heinzle, J.; Stephan, K. E.: Model-based prediction of muscarinic receptor function from auditory mismatch negativity responses. NeuroImage 237, 118096 (2021)

Craig, A.; Kolks, N.; Urosova, E. A.; Zischler, J.; Brugger, M.; Endepols, H.; Neumaier, B.; Zlatopolskiy, B. D.: Preparation of labeled aromatic amino acids via late-stage 18F-fluorination of chiral nickel and copper complexes. Chemical Communications 56 (66), S. 9505 - 9508 (2020)

Rohleder, C.; Pahlisch, F.; Graf, R.; Endepols, H.; Leweke, F. M.: Different pharmaceutical preparations of Δ 9 -tetrahydrocannabinol differentially affect its behavioral effects in rats. Addiction Biology, e12745 (2020)

Zlatopolskiy, B. D.; Endepols, H.; Krasikova, R. N.; Fedorova, O. S.; Ermert, J.; Neumaier, B.: C-11- and F-18-labelled tryptophans as PET-tracers for imaging of altered tryptophan metabolism in age-associated disorders. Russian Chemical Reviews 89 (9), S. 879 - 896 (2020)

Apetz, N.; Kordys, E.; Simon, M.; Mang, B.; Aswendt, M.; Wiedermann, D.; Neumaier, B.; Drzezga, A.; Timmermann, L.; Endepols, H.: Effects of subthalamic deep brain stimulation on striatal metabolic connectivity in a rat hemiparkinsonian model. Disease Models and Mechanisms 12 (5), UNSP dmm039065 (2019)

Modemann, D. J.; Zlatopolskiy, B. D.; Urusova, E. A.; Zischler, J.; Austin, C.; Ermert, J.; Guliyev, M.; Endepols, H.; Neumaier, B.: 2-[ 18 F]Fluorophenylalanine: synthesis by nucleophilic 18 F-fluorination and preliminary biological evaluation. Synthesis 51 (3), S. 664 - 676 (2019)

Zlatopolskiy, B. D.; Endepols, H.; Krapf, P.; Guliyev, M.; Urusova, E. A.; Richarz, R.; Hohberg, M.; Dietlein, M.; Drzezga, A.; Neumaier, B.: Discovery of F-18-JK-PSMA-7, a PET probe for the detection of small PSMA-positive lesions. Journal of Nuclear Medicine 60 (6), S. 817 - 823 (2019)

Endepols, H.; Mottaghy, F. M.; Simsekyilmaz, S.; Bucerius, J.; Vogt, F.; Winz, O.; Richarz, R.; Krapf, P.; Neumaier, B.; Zlatopolskiy, B. D. et al.; Morgenroth, A.: In vivo molecular imaging of glutamate carboxypeptidase II expression in reendothelialisation after percutaneous balloon denudation in a rat model. Scientific Reports 8 (1), 7411 (2018)

Zlatopolskiy, B. D.; Zischler, J.; Schaefer, D.; Urusova, E. A.; Guliyev, M.; Bannykh, O.; Endepols, H.; Neumaier, B.: Discovery of 7-[F-18]fluorotryptophan as a novel positron emission tomography (PET) probe for the visualization of tryptophan metabolism in vivo. Journal of Medicinal Chemistry 61 (1), S. 189 - 206 (2018)

Kordys, E.; Apetz, N.; Schneider, K.; Duncan, E.; Büschbell, B.; Rohleder, C.; Sué, M.; Drzezga, A.; Neumaier, B.; Timmermann, L. et al.; Endepols, H.: Motor impairment and compensation in a hemiparkinsonian rat model: correlation between dopamine depletion severity, cerebral metabolism and gait patterns. EJNMMI Research 7, S. 1 - 11 (2017)

Backes, H.; Walberer, M. I.; Ladwig, A.; Rueger, M. A.; Neumaier, B.; Endepols, H.; Höhn, M.; Fink, G. R.; Schroeter, M.; Graf, R.: Glucose consumption of inflammatory cells masks metabolic deficits in the brain. NeuroImage 128, S. 54 - 62 (2016)

Braun, R.; Klein, R.; Walter, H. L.; Ohren, M.; Freudenmacher, L.; Getachew, K.; Ladwig, A.; Luelling, J.; Neumaier, B.; Endepols, H. et al.; Graf, R.; Höhn, M.; Fink, G. R.; Schroeter, M.; Rueger, M. A.: Transcranial direct current stimulation accelerates recovery of function, induces neurogenesis and recruits oligodendrocyte precursors in a rat model of stroke. Experimental Neurology 279, S. 127 - 136 (2016)

Rohleder, C.; Wiedermann, D.; Neumaier, B.; Drzezga, A.; Timmermann, L.; Graf, R.; Leweke, F. M.; Endepols, H.: The functional networks of prepulse inhibition: Neuronal connectivity analysis based on FDG-PET in awake and unrestrained rats. Frontiers in Behavioral Neuroscience 10, 148 (2016)